Diclofenac Induced Toxic Epidermal Necrolysis: A Case Report

Main Article Content

Thota Raviteja Reddy
A. Sankar


Toxic epidermal necrosis (TEN) is a potentially fatal cutaneous condition that is typically brought on by medication. One of the most frequent classes of medications linked to drug-induced TEN are non-steroidal anti-inflammatory medicines (NSAIDS)(1,2).  Diclofenac is a recently developed NSAID that preferentially inhibits cyclooxygenase-2. It is frequently employed in the treatment of musculoskeletal conditions. In this report, a 80-year-old woman who received an IM diclofenac injection for bodily symptoms is described as having TEN caused by the drug.

Article Details

How to Cite
Umashankar, Reddy, T. R. ., Sankar, A. ., Madhuri, & Adithya. (2023). Diclofenac Induced Toxic Epidermal Necrolysis: A Case Report. Journal of Coastal Life Medicine, 11(1), 224–226. Retrieved from https://www.jclmm.com/index.php/journal/article/view/315


Gopalakrishnan, S., Ganeshkumar, P., & Katta, A. (2013). Assessment of prescribing practices among urban and rural general practitioners in Tamil Nadu. Indian journal of pharmacology , 45 (3), 252.

Ingrasciotta, Y., Sultana, J., Giorgianni, F., Menditto, E., Scuteri, A., Tari, M., ... & Trifiro’, G. (2019). Analgesic drug use in elderly persons: A population-based study in Southern Italy. PLoS One , 14 (9), e0222836.

Bushra, R., Shoaib, M. H., Naeem, M. I., & Aslam, N. (2013). Aceclofenac: A new effective and safe NSAID. International Journal of Drug Delivery Technology , 42 (4), 1.

Goutham, S., & Rajendran, N. (2019). Patterns of Cutaneous Drug Reactions: A Review. SBV J Basic, Clin Appl Heal Sci , 2 , 134-7.

Ludwig, C., Brinkmeier, T., & Frosch, P. J. (2003). Exudative erythema multiforme with transition to a toxic epidermal necrolysis after taking aceclofenac (Beofenac). Deutsche Medizinische Wochenschrift (1946) , 128 (10), 487-490.

Ameen, K. H. N., Pinninti, R., & Jami, S. (2013). Aceclofenac induced Stevens-Johnson/toxic epidermal necrolysis overlap syndrome. Journal of Pharmacology & Pharmacotherapeutics , 4 (1), 69.

World Health Organization (WHO), Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment. WHO [online]. Available from URL: http://www.who- umc.org/graphics/4409.pdf [Accessed 2022 April 30]

Oakley, A. M., & Krishnamurthy, K. (2021). Stevens Johnson Syndrome. StatPearls [Internet] .

Cheng, L. (2021). Current pharmacogenetic perspective on stevens-johnson syndrome and toxic epi- dermal necrolysis. Frontiers in Pharmacology , 12 , 195.

Lee, H. Y., Walsh, S. A., & Creamer, D. (2017). Long-term complications of Stevens–Johnson syn- drome/toxic epidermal necrolysis (SJS/TEN): the spectrum of chronic problems in patients who sur- vive an episode of SJS/TEN necessitates multidisciplinary follow-up. British Journal of Dermatology , 177 (4), 924-935.